Stiefel (nine products) Overview
- Year Founded
-
2001
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Stiefel (nine products) General Information
Description
Stiefel, a GlaxoSmithKline company, sold off nine dermatology products to Renaissance Pharma. Renaissance Pharma was given the rights to manufacture, market and sell all nine products. These products from GSK and Stiefel, which will be marketed through Renaissance's branded division Prestium Pharma ("Prestium"), include: 1. Evoclin® (clindamycin phosphate) Foam, 1% 2. Extina® (ketoconazole) Foam, 2% 3. Luxiq® (betamethasone valerate) Foam, 0.12% 4. Olux® (clobetasol propionate) Foam, 0.05% 5. Olux-E® (clobetasol propionate) Foam, 0.05% 6. Vusion® (miconazole nitrate 0.25%, zinc oxide 15% and white petrolatum 81.35%) Ointment 7. Zovirax® (acyclovir) Capsules 8. Zovirax® (acyclovir) Tablets 9. Zovirax® (acyclovir) Suspension
Contact Information
Website
www.stiefel.comCorporate Office
- 20 T.W. Alexander Drive
- Durham, NC 27709
- United States
Corporate Office
- 20 T.W. Alexander Drive
- Durham, NC 27709
- United States
Stiefel (nine products) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Stiefel (nine products) Patents
Stiefel (nine products) Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20160081895-A1 | Novel formulations | Inactive | 18-Sep-2014 | ||
| WO-2014182655-A1 | Assay for screening a compound for the ability to modulate proinflammatory cytokine production in human skin | Inactive | 06-May-2013 | ||
| AU-2014218800-A1 | Non-aqueous solid stabilized emulsions | Active | 22-Feb-2013 | ||
| AU-2014218800-B2 | Non-aqueous solid stabilized emulsions | Inactive | 22-Feb-2013 | ||
| AU-2014218800-C1 | Non-aqueous solid stabilized emulsions | Inactive | 22-Feb-2013 | A61K8/0241 |
Stiefel (nine products) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Stiefel (nine products) FAQs
-
When was Stiefel (nine products) founded?
Stiefel (nine products) was founded in 2001.
-
Where is Stiefel (nine products) headquartered?
Stiefel (nine products) is headquartered in Durham, NC.
-
What industry is Stiefel (nine products) in?
Stiefel (nine products)’s primary industry is Pharmaceuticals.
-
Is Stiefel (nine products) a private or public company?
Stiefel (nine products) is a Private company.
-
What is Stiefel (nine products)’s current revenue?
The current revenue for Stiefel (nine products) is .
-
Who are Stiefel (nine products)’s investors?
GSK has invested in Stiefel (nine products).
-
When was Stiefel (nine products) acquired?
Stiefel (nine products) was acquired on 01-May-2013.
-
Who acquired Stiefel (nine products)?
Stiefel (nine products) was acquired by Renaissance Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process